{"abstract": "With an equity value of $152 billion, the merger is the largest since the heady days of 2000.", "web_url": "https://www.nytimes.com/2015/11/24/business/dealbook/how-the-pfizer-allergan-deal-ranks.html", "snippet": "With an equity value of $152 billion, the merger is the largest since the heady days of 2000.", "lead_paragraph": "The huge price tag accorded to the deal between Allergan and Pfizer \u2014 $160 billion in total enterprise value \u2014 is one of the largest in history and the biggest ever among pharmaceutical companies.", "source": "The New York Times", "multimedia": [{"rank": 0, "subtype": "xlarge", "caption": null, "credit": null, "type": "image", "url": "images/2015/11/24/business/24db-deal-web1/24db-deal-web1-articleLarge.jpg", "height": 393, "width": 600, "subType": "xlarge", "crop_name": "articleLarge", "legacy": {"xlarge": "images/2015/11/24/business/24db-deal-web1/24db-deal-web1-articleLarge.jpg", "xlargewidth": 600, "xlargeheight": 393}}, {"rank": 0, "subtype": "jumbo", "caption": null, "credit": null, "type": "image", "url": "images/2015/11/24/business/24db-deal-web1/24db-deal-web1-jumbo.jpg", "height": 671, "width": 1024, "subType": "jumbo", "crop_name": "jumbo", "legacy": {}}, {"rank": 0, "subtype": "superJumbo", "caption": null, "credit": null, "type": "image", "url": "images/2015/11/24/business/24db-deal-web1/24db-deal-web1-superJumbo.jpg", "height": 1342, "width": 2048, "subType": "superJumbo", "crop_name": "superJumbo", "legacy": {}}, {"rank": 0, "subtype": "thumbnail", "caption": null, "credit": null, "type": "image", "url": "images/2015/11/24/business/24db-deal-web1/24db-deal-web1-thumbStandard.jpg", "height": 75, "width": 75, "subType": "thumbnail", "crop_name": "thumbStandard", "legacy": {"thumbnail": "images/2015/11/24/business/24db-deal-web1/24db-deal-web1-thumbStandard.jpg", "thumbnailwidth": 75, "thumbnailheight": 75}}, {"rank": 0, "subtype": "thumbLarge", "caption": null, "credit": null, "type": "image", "url": "images/2015/11/24/business/24db-deal-web1/24db-deal-web1-thumbLarge.jpg", "height": 150, "width": 150, "subType": "thumbLarge", "crop_name": "thumbLarge", "legacy": {}}], "headline": {"main": "How the Pfizer-Allergan Deal Ranks", "kicker": null, "content_kicker": null, "print_headline": "", "name": null, "seo": null, "sub": null}, "keywords": [{"name": "subject", "value": "Mergers, Acquisitions and Divestitures", "rank": 1, "major": "N"}, {"name": "subject", "value": "Drugs (Pharmaceuticals)", "rank": 2, "major": "N"}, {"name": "organizations", "value": "ALLERGAN INC", "rank": 3, "major": "N"}, {"name": "organizations", "value": "Pfizer Inc", "rank": 4, "major": "N"}, {"name": "organizations", "value": "Vodafone Group Plc", "rank": 5, "major": "N"}, {"name": "organizations", "value": "Mannesmann AG", "rank": 6, "major": "N"}, {"name": "organizations", "value": "Time Warner Inc", "rank": 7, "major": "N"}], "pub_date": "2015-11-23T18:49:32+0000", "document_type": "article", "news_desk": "Business", "section_name": "Business Day", "subsection_name": "DealBook", "byline": {"original": "By Leslie Picker", "person": [{"firstname": "Leslie", "middlename": null, "lastname": "Picker", "qualifier": null, "title": null, "role": "reported", "organization": "", "rank": 1}], "organization": null}, "type_of_material": "News", "_id": "nyt://article/47ec9b96-e47c-517c-9f8b-df52fc507d92", "word_count": 275, "uri": "nyt://article/47ec9b96-e47c-517c-9f8b-df52fc507d92"}